Back
Indivior PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
63
INDV
Indivior PLC
Last Price:
11.65
Seasonality Move:
8.47%
Sell
37
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.64
Seasonality Move:
29.88%
Buy
63
Indivior PLC (INDV)
is a Buy
Is Indivior PLC a Buy, Sell or Hold?
- The current Indivior PLC [INDV] share price is $11.65. The Score for INDV is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- INDV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INDV Stock Price Chart
What is Indivior PLC's stock price today?
-
The Indivior PLC share price today is $11.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INDV is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.
INDV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 68.84 | Buy |
| Chaikin Money Flow: | 466511 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.18 - 11.4) | Buy |
| Bollinger Bands (100): | (9.14 - 12.28) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 38.79 | Sell |
| Chaikin Money Flow: | 315808 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.62 - 0.76) | Sell |
| Bollinger Bands (100): | (0.73 - 1.15) | Sell |
INDV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.4 | Buy |
| 20-day SMA: | 10.93 | Buy |
| 50-day SMA: | 9.87 | Buy |
| 200-day SMA: | 14.3 | Sell |
| 8-day EMA: | 11.41 | Buy |
| 20-day EMA: | 10.97 | Buy |
| 50-day EMA: | 10.53 | Buy |
| 200-day EMA: | 13.15 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.67 | Sell |
| 20-day SMA: | 0.67 | Sell |
| 50-day SMA: | 0.76 | Sell |
| 200-day SMA: | 1.08 | Sell |
| 8-day EMA: | 0.66 | Sell |
| 20-day EMA: | 0.69 | Sell |
| 50-day EMA: | 0.77 | Sell |
| 200-day EMA: | 0.96 | Sell |
Indivior PLC Earnings Growth & INDV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and a decrease next year of $0.04 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.
Indivior PLC Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||